// App-Quantinova.ai

Su1354 : Factors Associated With Large Increases in Self-Reported Health Status in Infliximab-Treated IBD Patients

Researchers

Presenter

  • Kuhan Perampaladas

Principal Investigators

  • Martin Williamson

  • Steve Kanters

  • Kristian Thorlund

Medical Centers

  • University of Saskatchewan, Saskatoon, SK, Canada

  • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada

  • Epidemiology & Biostatistics, University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • Janssen Global Servi

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

  • Crohn's disease

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim